Abnormalities in myocardial contractility, metabolism and perfusion reserve in non-stenotic coronary segments in heart failure patients

Cardiovasc Res. 2002 Jul;55(1):97-103. doi: 10.1016/s0008-6363(02)00331-0.

Abstract

Objective: Myocardial blood flow (MBF) reserve is impaired in congestive heart failure (CHF), while fluorine-18-deoxyglucose (18FDG) uptake is relatively preserved. To determine whether this mismatch could be interpreted as ischemia, we performed dobutamine stress echocardiography (DSE).

Methods: 12 males with coronary artery disease (CAD) and CHF were compared with 12 controls with similar CAD but normal left ventricular (LV) function. MBF in non-infarct-related artery areas was assessed using [(13)N]ammonia positron emission tomography (PET), at rest and after dipyridamole infusion and 18FDG uptake was determined. DSE was performed with doses up to 40 microg/kg per min.

Results: In areas with non-stenotic arteries MBF reserve was more impaired in CHF patients (1.6+/-0.6 vs. 2.2+/-0.5; CHF versus normal LV, respectively, P<0.05). MBF reserve was related to LV ejection fraction (r=0.6, P<0.05) and wall stress (r=-0.72, P<0.05). PET showed mismatch in 4+/-1% of the myocardium in normal LV, compared to 26+/-26% in CHF (P<0.05), coinciding with more ischemic wall motion abnormalities on DSE (21 vs. 4%; CHF versus normal LV, respectively, P<0.05).

Conclusions: In CHF, mismatch was found in areas supplied by non-stenotic coronary arteries. Corresponding areas showed ischemic wall motions on DSE. These findings suggest that the condition of CHF may play a role in perpetuating myocardial failure by inducing myocardial ischemia. Follow-up studies to investigate the ischemia-CHF relationship in time would be needed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Case-Control Studies
  • Coronary Angiography
  • Coronary Circulation
  • Coronary Disease / diagnostic imaging*
  • Coronary Disease / metabolism
  • Dipyridamole
  • Echocardiography, Stress*
  • Energy Metabolism
  • Fluorodeoxyglucose F18 / pharmacokinetics
  • Heart Failure / diagnostic imaging
  • Heart Failure / metabolism
  • Humans
  • Male
  • Middle Aged
  • Myocardial Contraction*
  • Myocardial Ischemia / diagnostic imaging
  • Myocardial Ischemia / metabolism
  • Myocardium / metabolism
  • Perfusion
  • Tomography, Emission-Computed
  • Vasodilator Agents

Substances

  • Vasodilator Agents
  • Fluorodeoxyglucose F18
  • Dipyridamole